Department of Health and Human Services Secretary Robert F. Kennedy Jr. has endorsed a Centers for Disease Control and Prevention advisory committee recommendation banning the use of thimerosal in all vaccines in the U.S. RFK Jr. and other anti - vaccine activists have said that the preservative, which contains mercury, can cause autism, while studies have shown no link. (Department of Health and Human Services)
美国卫生与公众服务部部长小罗伯特・F・肯尼迪已认可美国疾病控制与预防中心咨询委员会的一项建议，即禁止在美国所有疫苗中使用硫柳汞。小肯尼迪和其他反疫苗活动人士称这种含汞的防腐剂会导致自闭症，尽管研究表明（二者）并无关联。（卫生与公众服务部）

Last month, RFK Jr.’s revamped Advisory Committee on Immunization Practices (ACIP) recommended against the use of thimerosal in flu shots. In three separate rounds of voting, the ACIP advised that children, pregnant women and adults should not receive vaccines that contain thimerosal. Each of the votes were 5 - 1 in favor of removing thimerosal from vaccines, with one committee member abstaining.
上个月，美国免疫实践咨询委员会（ACIP）建议在流感疫苗中不使用硫柳汞。在三轮独立投票中，该委员会建议儿童、孕妇和成人不应接种含硫柳汞的疫苗。每一轮投票结果都是 5 票赞成、1 票弃权，支持从疫苗中去除硫柳汞 。

“After more than two decades of delay, this action fulfills a long - overdue promise to protect our most vulnerable populations from unnecessary mercury exposure,” RFK Jr. said in a release. “Injecting any amount of mercury into children when safe, mercury - free alternatives exist defies common sense and public health responsibility. Today, we put safety first.”
小肯尼迪在一份声明中表示：“经过二十多年的拖延，这一行动实现了一项早就该兑现的承诺，即保护我们最脆弱的人群免受不必要的汞暴露。当存在安全、不含汞的替代物时，还向儿童注射任何剂量的汞，既违背常识，也有悖公共卫生责任。如今，我们将安全放在首位。”

Most companies have already removed the preservative from their vaccines. The exceptions are Sanofi, which produces multidose vials of Fluzone in addition to single - dose syringes, and CSL Seqirus, which includes thimerosal in its multidose vials of Afluria and Flucelvax. Each of these flu shots include a 0.01% concentration of thimerosal.
大多数公司已从其疫苗中去除了这种防腐剂。例外情况是赛诺菲（Sanofi）和 CSL Seqirus 公司 ，赛诺菲除了生产单剂量注射器外，还生产多剂量瓶的 Fluzone 疫苗；CSL Seqirus 在其多剂量瓶的 Afluria 和 Flucelvax 疫苗中含有硫柳汞。这些流感疫苗中硫柳汞的浓度均为 0.01% 。

“We acknowledge the recommendation of the new (ACIP),” a Sanofi spokesperson said in a brief statement. “We will have sufficient supply of Sanofi flu vaccine to support customer preference for this season.”
赛诺菲的一位发言人在一份简短声明中表示：“我们认可新的（ACIP）建议。我们将有充足的赛诺菲流感疫苗供应，以满足本季客户的偏好。”

Meanwhile, a spokesperson from CSL Seqirus said that “delivery of our thimerosal - free flu vaccines for the upcoming season is already underway and we don’t expect the ACIP recommendation to have any impact on our vaccine supply or shipment timings.”
与此同时，CSL Seqirus 的一位发言人表示：“我们为下一季准备的不含硫柳汞的流感疫苗的交付工作已经在进行中，我们预计 ACIP 的建议不会对我们的疫苗供应或发货时间产生任何影响。”